BBSRC Portfolio Analyser

BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameMr Bob Bundick
Current InstitutionAstraZeneca plc
Current DepartmentAstraZeneca Charnwood
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
01/A2/S/07380 Discordant IgE synthesis and eosinophilia Co-Supervisor 39,328 Studentships
97/A3/S/03830 Novel sources of the pro-allergic cytokine IL-5 Co-Supervisor 32,558 Studentships
terms and conditions of use (opens in new window)
export PDF file
back to list new search